MedNews is an independent publication established in 2021 to provide unique, premium news and insightful commentary on the pharmaceutical, biotech and related tech industries in Australia and New Zealand. The focus of MedNews is access to new and affordable therapies in Australia and competitive analysis of the market, both innovative and generic. We cover businesses, products, government policy, politics, people, legal, leadership and workplace, telling stories in such a way that people working in and with medical health are better informed, engaged and connected. To sign up for our free morning newsletter, go to https://mednews.com.au/newsletter/ To subscribe, go to https://mednews.com.au/register/